Aldehyde dehydrogenase 1 (ALDH1) activity also marks breast cancer cells enriched for stem cell properties and those with both ALDH1+ and CD44+CD24neg/low are most tumourigenic, but infrequent (<1%; Ginestier et al, 2007). The gene discussed is CD44; the disease is breast carcinoma.